Open Access
| Issue |
BIO Web Conf.
Volume 61, 2023
6th International Conference on Frontiers of Biological Sciences and Engineering (FBSE 2023)
|
|
|---|---|---|
| Article Number | 01019 | |
| Number of page(s) | 5 | |
| DOI | https://doi.org/10.1051/bioconf/20236101019 | |
| Published online | 21 June 2023 | |
- Sampath, V., et al., Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy, 2021. 76(6): p. 1640-1660. [CrossRef] [PubMed] [Google Scholar]
- Rai, P., et al., Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol, 2021. 105(2): p. 441-455. [CrossRef] [PubMed] [Google Scholar]
- Guarner, J., Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol, 2020. 153(4): p. 420-421. [CrossRef] [PubMed] [Google Scholar]
- Abdelrahman, Z., M. Li, and X. Wang, Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front Immunol, 2020. 11: p. 552909. [CrossRef] [PubMed] [Google Scholar]
- Chen, Y., Q. Liu, and D. Guo, Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol, 2020. 92(4): p. 418-423. [CrossRef] [Google Scholar]
- Alanagreh, L., F. Alzoughool, and M. Atoum, The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens, 2020. 9(5). [Google Scholar]
- Chaudhary, J.K., et al., Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Cells, 2021. 10(11). [Google Scholar]
- Lu, R., et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020. 395(10224): p. 565-574. [CrossRef] [PubMed] [Google Scholar]
- Yang, M., et al., Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Microbiol Spectr, 2021. 9(2): p. e0135221. [CrossRef] [PubMed] [Google Scholar]
- Alsharif, W. and A. Qurashi, Effectiveness of COVID-19 diagnosis and management tools: A review. Radiography (Lond), 2021. 27(2): p. 682-687. [CrossRef] [PubMed] [Google Scholar]
- Ai, T., et al., Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, 2020. 296(2): p. E32-e40. [CrossRef] [PubMed] [Google Scholar]
- Gaunt, E.R., et al., Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol, 2010. 48(8): p. 2940-7. [CrossRef] [PubMed] [Google Scholar]
- Sidiq, Z., et al., Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc, 2020. 67(4s): p. S163-s166. [CrossRef] [PubMed] [Google Scholar]
- Faiq, M.A., B-cell engineering: A promising approach towards vaccine development for COVID-19. Med Hypotheses, 2020. 144: p. 109948. [CrossRef] [PubMed] [Google Scholar]
- Mistry, P., et al., SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front Immunol, 2021. 12: p. 809244. [Google Scholar]
- Su, S., et al., Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol, 2016. 24(6): p. 490-502. [CrossRef] [PubMed] [Google Scholar]
- Anand, U., et al., Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol, 2021. 12: p. 658519. [CrossRef] [PubMed] [Google Scholar]
- Sharma, O., et al., A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Front Immunol, 2020. 11: p. 585354. [CrossRef] [PubMed] [Google Scholar]
- Melo-González, F., et al., Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine. Front Immunol, 2021. 12: p. 747830. [CrossRef] [PubMed] [Google Scholar]
- Zhang, Y., et al., Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis, 2021. 21(2): p. 181-192. [CrossRef] [PubMed] [Google Scholar]
- Ochani, R., et al., COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med, 2021. 29(1): p. 20-36. [PubMed] [Google Scholar]
- Sreepadmanabh, M., A.K. Sahu, and A. Chande, COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci, 2020. 45(1). [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.